NASDAQ:TFFP
Tff Pharmaceuticals, Inc. Stock News
$2.09
-0.110 (-5.00%)
At Close: May 08, 2024
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2021 Results - Earnings Call Transcript
11:06pm, Thursday, 12'th Aug 2021
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2021 Results - Earnings Call Transcript
Augmenta - TFF Pharma's COVID-19 Antibody Shows Preclinical Activity Against Delta Variant
10:13am, Thursday, 29'th Jul 2021
Augmenta Bioworks and TFF Pharmaceuticals Inc (NASDAQ: TFFP) have announced positive in vitro data indicating that their lead anti-COVID-19 monoclonal antibody, AUG-3387, binds to and neutralizes
Data Shows AUG-3387 Neutralizes SARS-CoV-2 Delta Variant in Infective Assays
TFF Pharmaceuticals to Participate in the BTIG Virtual Biotechnology Conference
08:00am, Wednesday, 28'th Jul 2021
AUSTIN, Texas, July 28, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug product
TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic
02:04am, Tuesday, 27'th Jul 2021
The shares of TFFP have slumped, most likely as a result of disappointment over an absence of a deal with one of the top mRNA vaccine producers. However, besides a host of programs developed alone or
TFF Pharmaceuticals (TFFP) Completes Enrollment in Phase I Study
04:55pm, Wednesday, 14'th Jul 2021
TFF Pharmaceuticals (TFFP) completes enrollment in the phase I study on tacrolimus inhalation powder and announces positive preliminary data.
New Strong Sell Stocks for July 8th
09:47am, Thursday, 08'th Jul 2021
CLPR, IONS, RAD, TFFP, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on July 8, 2021
TFF Pharmaceuticals: Looking Attractive At These Prices
04:47pm, Thursday, 03'rd Jun 2021
TFFP has a thin-film technology that produces inhalable powdered forms of common drugs, with various advantages over existing methods.
TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
05:09pm, Tuesday, 25'th May 2021
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products
TFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call Transcript
11:07pm, Thursday, 13'th May 2021
TFF Pharmaceuticals' (TFFP) CEO Glenn Mattes on Q1 2021 Results - Earnings Call Transcript
TFF Pharmaceuticals to Hold First Quarter 2021 Financial and Business Results Conference Call on May 13, 2021
08:32am, Tuesday, 04'th May 2021
AUSTIN, Texas--(BUSINESS WIRE)---- $TFFP #earnings--TFF Pharmaceuticals to hold first quarter 2021 financial and business results conference call on May 13, 2021 at 4:30 PM EDT
TFF Pharmaceuticals: Not A Matter Of If, But When The Shares Will Run Much Higher
04:34pm, Friday, 19'th Mar 2021
The company's generic technology provides important benefits and is applicable in a wide range of situations. The company has two dozen shots at goal and is still adding.
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2020 Results - Earnings Call Transcript
09:45pm, Wednesday, 10'th Mar 2021
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2020 Results - Earnings Call Transcript
MEDFORD, Mass. & AUSTIN, Texas--(BUSINESS WIRE)---- $TFFP #COVID--GreenLight Biosciences and TFF Pharmaceuticals enter into feasibility arrangement for shelf-stable powder form of messenger RNA COVID-
Why Earnings Season Could Be Great for TFF Pharmaceuticals (TFFP)
09:51am, Monday, 08'th Mar 2021
TFF Pharmaceuticals (TFFP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
